Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

Montefiore Medical Center - Moses Campus, The Bronx

State University of New York Upstate Medical University, Syracuse

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

Children's Hospital of Philadelphia, Philadelphia

Alfred I duPont Hospital for Children, Wilmington

MedStar Georgetown University Hospital, Washington D.C.

Children's National Medical Center, Washington D.C.

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

Children's Hospital of The King's Daughters, Norfolk

University of Florida Health Science Center - Gainesville, Gainesville

Nicklaus Children's Hospital, Miami

Children's Hospital of Alabama, Birmingham

Vanderbilt University/Ingram Cancer Center, Nashville

Saint Jude Children's Research Hospital, Memphis

Norton Children's Hospital, Louisville

Cincinnati Children's Hospital Medical Center, Cincinnati

Riley Hospital for Children, Indianapolis

C S Mott Children's Hospital, Ann Arbor

Lurie Children's Hospital-Chicago, Chicago

Children's Mercy Hospitals and Clinics, Kansas City

University of Oklahoma Health Sciences Center, Oklahoma City

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Children's Hospital of San Antonio, San Antonio

Children's Hospital Colorado, Aurora

Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver

Arkansas Children's Hospital, Little Rock

Hackensack University Medical Center, Hackensack

Centre Hospitalier Universitaire Sainte-Justine, Montreal